Author:
Li Jianan,Chen Yixin,Zhang Minyu,Zhang Peifang,He Kunlun,Yan Fengqin,Li Jingbo,Xu Hong,Burkhoff Daniel,Luo Yukun,Wang Longxia,Li Qiuyang
Abstract
Appropriate clinical management of adnexal masses requires a detailed diagnosis. We retrospectively collected ultrasound images of 1559 cases from the first Center of Chinese PLA General Hospital and developed a fully automatic deep learning (DL) model system to diagnose adnexal masses. The DL system contained five models: a detector, a mass segmentor, a papillary segmentor, a type classifier, and a pathological subtype classifier. To test the DL system, 462 cases from another two hospitals were recruited. The DL system identified benign, borderline, and malignant tumors with macro-F1 scores that varied from 0.684 to 0.791, a benefit to preventing both delayed and overextensive treatment. The macro-F1 scores of the pathological subtype classifier to categorize the benign masses varied from 0.714 to 0.831. The detailed classification can inform clinicians of the corresponding complications of each pathological subtype of benign tumors. The distinguishment between borderline and malignant tumors and inflammation from other subtypes of benign tumors need further study. The accuracy and sensitivity of the DL system were comparable to that of the expert and intermediate sonographers and exceeded that of the junior sonographer.
Funder
the artificial intelligence public service platform for screening and auxiliary diagnosis of medical and health conditions
Reference44 articles.
1. Risk of complications in patients with conservatively managed ovarian tumours (IOTA5): A 2-year interim analysis of a multicentre, prospective, cohort study;Froyman;Lancet. Oncol.,2019
2. American College of Obstetricians and Gynecologists’ Committee on Practice Bulletins—Gynecology (2016). Practice Bulletin No. 174: Evaluation and Management of Adnexal Masses. Obstet. Gynecol., 128, e210–e226.
3. O-RADS US Risk Stratification and Management System: A Consensus Guideline from the ACR Ovarian-Adnexal Reporting and Data System Committee;Andreotti;Radiology,2020
4. Carcinoma of the ovary. FIGO 26th Annual Report on the Results of Treatment in Gynecological Cancer;Heintz;Int. J. Gynaecol. Obstet. Off. Organ Int. Fed. Gynaecol. Obstet.,2006
5. Ovarian Cancer, Version 2.2020, NCCN Clinical Practice Guidelines in Oncology;Armstrong;J. Natl. Compr. Cancer Netw. JNCCN,2021